Bladder cancer is the seventh most common cancer in men, less common in women. However, bladder cancer is a more deadly cancer in women. The American Cancer Society estimates that 80,000 people (62,000 men, 18,000 women) will be diagnosed with bladder cancer in 2019 in the United States.

Although it is usually seen after the age of 50, the diagnosis and treatment of bladder cancer or benign tumors of the bladder, which can occur at any age, are carried out by urology doctors. Since there are surgical methods in the treatment of bladder cancer and benign bladder tumors, it is important to choose a urology doctor specialized in this field.

The depth of the cancerous tumor in the bladder wall and the degree of the tumor. Whether the bladder tumor has spread to the regional lymph nodes. It is examined whether the bladder cancer has metastasized to other organs such as the lung or liver.

The follow-up process is very important in bladder cancer patients, as there is a risk of recurrence (recurrence) of bladder cancer after treatment. Follow-up is an important part of cancer treatment. Follow-up after bladder cancer treatment may vary depending on the stage and grade of the cancer and the type of treatment applied. Bladder cancer has a high probability of recurrence in the first 2 years after treatment, after which the follow-up is extended up to 10 years, although the probability of recurrence decreases.

Bladder cancer most commonly metastasizes to the lungs, liver, or bones.